A detailed history of Concourse Financial Group Securities, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 12,733 shares of BMY stock, worth $741,442. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,733
Previous 12,478 2.04%
Holding current value
$741,442
Previous $518,000 27.03%
% of portfolio
0.04%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$39.66 - $51.75 $10,113 - $13,196
255 Added 2.04%
12,733 $658,000
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $36,426 - $47,955
-905 Reduced 6.76%
12,478 $518,000
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $40,591 - $46,022
-846 Reduced 5.95%
13,383 $725,000
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $1.32 Million - $1.58 Million
-27,326 Reduced 65.76%
14,229 $730,000
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $327,599 - $366,307
-5,659 Reduced 11.99%
41,555 $2.41 Million
Q2 2023

Aug 10, 2023

BUY
$63.71 - $70.74 $15,035 - $16,694
236 Added 0.5%
47,214 $3.02 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $124,980 - $141,756
1,902 Added 4.22%
46,978 $3.26 Million
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $104,295 - $123,500
1,523 Added 3.5%
45,076 $0
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $472 - $279,006
3,631 Added 9.1%
43,553 $3.1 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $113,214 - $124,688
-1,559 Reduced 3.76%
39,922 $3.1 Million
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $532,293 - $638,267
-8,658 Reduced 17.27%
41,481 $3.05 Million
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $367,258 - $428,136
-6,848 Reduced 12.02%
50,139 $3.13 Million
Q3 2021

Nov 09, 2021

SELL
$59.17 - $69.31 $55,264 - $64,735
-934 Reduced 1.61%
56,987 $3.4 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $117,133 - $127,558
1,892 Added 3.38%
57,921 $3.87 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $138,914 - $156,238
2,341 Added 4.36%
56,029 $3.56 Million
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $181,303 - $205,450
3,140 Added 6.21%
53,688 $3.36 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $72,821 - $80,695
1,268 Added 2.57%
50,548 $3.05 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $106,405 - $124,398
1,941 Added 4.1%
49,280 $2.9 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $96,419 - $140,119
2,078 Added 4.59%
47,339 $2.64 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $1.57 Million - $2.05 Million
31,934 Added 239.62%
45,261 $2.91 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $1.4 Million - $1.66 Million
-32,830 Reduced 71.13%
13,327 $676,000
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $996,944 - $1.1 Million
22,343 Added 93.82%
46,157 $2.09 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $14,664 - $17,485
-325 Reduced 1.35%
23,814 $1.14 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $654,846 - $849,178
13,430 Added 125.41%
24,139 $1.25 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $591,029 - $666,635
10,709 New
10,709 $665,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.